| 1 |
2024 |
Yogita Dhas, Nupur Biswas, Divyalakshmi M.R., Lawrence D. Jones, Shashaanka Ashili. Repurposing metabolic regulators: antidiabetic drugs as anticancer agents, Molecular Biomedicine. 2024; 5: 40.
https://doi.org/10.1186/s43556-024-00204-z |
| 2 |
2024 |
Monika Pliszka, Leszek Szablewski. Associations between Diabetes Mellitus and Selected Cancers, International Journal of Molecular Sciences. 2024; 25: 7476.
https://doi.org/10.3390/ijms25137476 |
| 3 |
2023 |
Lara Murphy, Diana Sherifali, Muhammad Usman Ali, Sarah Ibrahim. Influence of Diabetes Mellitus on Oncological Outcomes for Patients Living With Cancer, The Science of Diabetes Self-Management and Care. 2023; 49: 163.
https://doi.org/10.1177/26350106231153073 |
| 4 |
2024 |
Agostino Milluzzo, Lucia Manuella, Lucia Frittitta, Laura Sciacca. Cancer drugs and diabetic retinopathy: a dangerous, underestimated association, Metabolism and Target Organ Damage. 2024; 4:
https://doi.org/10.20517/mtod.2023.43 |
| 5 |
2023 |
Matheus Correia Casotti, Débora Dummer Meira, Lyvia Neves Rebello Alves, Barbara Gomes de Oliveira Bessa, Camilly Victória Campanharo, Creuza Rachel Vicente, Carla Carvalho Aguiar, Daniel de Almeida Duque, Débora Gonçalves Barbosa, Eldamária de Vargas Wolfgramm dos Santos, Fernanda Mariano Garcia, Flávia de Paula, Gabriel Mendonça Santana, Isabele Pagani Pavan, Luana Santos Louro, Raquel Furlani Rocon Braga, Raquel Silva dos Reis Trabach, Thomas Santos Louro, Elizeu Fagundes de Carvalho, Iúri Drumond Louro. Translational Bioinformatics Applied to the Study of Complex Diseases, Genes. 2023; 14: 419.
https://doi.org/10.3390/genes14020419 |
| 6 |
2022 |
Chandrakala Aluganti Narasimhulu, Dinender K. Singla. Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals, Canadian Journal of Physiology and Pharmacology. 2022; 100: 441.
https://doi.org/10.1139/cjpp-2021-0596 |
| 7 |
2024 |
Custodia García-Jiménez, José Manuel García-Martínez, Ana Chocarro-Calvo. 2024; 231.
https://doi.org/10.1016/B978-0-323-88426-6.00003-8 |
| 8 |
2024 |
Leanne Osgood, Nyangi Gityamwi, Debbie Cooke. Evaluating oncology healthcare professionals’ knowledge of diabetes mellitus, Cancer Nursing Practice. 2024;
https://doi.org/10.7748/cnp.2024.e1880 |
| 9 |
2024 |
Sixten Harborg, Kasper A Kjærgaard, Reimar Wernich Thomsen, Signe Borgquist, Deirdre Cronin-Fenton, Cathrine F Hjorth. New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis, The Journal of Clinical Endocrinology & Metabolism. 2024; 109: 924.
https://doi.org/10.1210/clinem/dgad450 |
| 10 |
2023 |
Siti Nor Ain Wahid Satar, Mohd Noor Norhayati, Lili Husniati Yaacob. Recurrent hypoglycemia in a patient with hepatocellular carcinoma, Electronic Journal of General Medicine. 2023; 20: em465.
https://doi.org/10.29333/ejgm/12903 |
| 11 |
2022 |
Agostino Milluzzo, Lucia Manuella, Emanuela Cannata, Giovanna Russo, Sandro La Vignera, Francesco Purrello, Andrea Di Cataldo, Laura Sciacca. Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors, Journal of Clinical Medicine. 2022; 11: 878.
https://doi.org/10.3390/jcm11030878 |
| 12 |
2020 |
Erika Pedone, Andrea Laurenzi, Agnese Allora, Andrea Mario Bolla, Amelia Caretto. Insulin pump therapy and continuous glucose monitoring in adults with type 2 diabetes: where are we now?, Exploration of Medicine. 2020; 1: 314.
https://doi.org/10.37349/emed.2020.00021 |
| 13 |
2024 |
Agostino MILLUZZO, Martina BARCHITTA, Andrea MAUGERI, Antonella AGODI, Laura SCIACCA. Body Mass Index is related to short-term retinal worsening in type 2 diabetes mellitus patients treated with anticancer drugs, Minerva Endocrinology. 2024; 49:
https://doi.org/10.23736/S2724-6507.22.03653-3 |
